Pikkelysömör: vizsgálatok itt: Olaszország

In Olaszország 22 Also abroad 274

22 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.

4. fázisTaking people
An open-label, multi-center protocol for patients who have completed a previous Novartis sponsored Secukinumab study and are judged by the investigator to benefit from continued Secukinumab treatment
Where
Florence, Reggio Emilia
People
339 worldwide
Run by
Novartis Pharma AG
See details and how to joinNCT04638647 · EU 2023-504417-67-00
3. fázisTaking people
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Where
Bergamo, Bologna, Rome, San Giovanni Rotondo, Trieste
Életkor
3 év to 64 év
People
196 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00
No phaseTaking people
A Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World Setting
Where
Bari, Brescia, Iesi, Milan, Naples, Palermo, Pavia, Perugia, Pisa, Potenza, Reggio Emilia, Roma, Siena, Torino, Varese, Verona
Életkor
18 év and over
People
200
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07220824
3. fázisTaking people
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Where
Cagliari, Chieti Scalo, L'aquila, Modena, Naples, Rome, Rozzano
Életkor
40 év and over
People
3040 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07116967 · EU 2023-503766-24-00
3. fázisTaking people
A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Where
Bologna, Rome
Életkor
12 év to 17 év
People
366 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT06979453 · EU 2023-506296-97-00
No phaseTaking people
Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
Where
Rome
Életkor
Up to 21 év
People
20 000 worldwide
Run by
Duke University
See details and how to joinNCT02418442
3. fázisTaking people
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
Where
Ancona, Florence, Milan, Padova, Pisa, Rome, Rozzano
Életkor
18 év and over
People
1088 worldwide
Run by
Takeda
See details and how to joinNCT06671483 · EU 2024-513111-27-00
No phaseTaking people
Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis
Where
Genova, L’Aquila, Milan, Naples, Rome
Életkor
18 év and over
People
700 worldwide
Run by
AbbVie
See details and how to joinNCT07039110
3. fázisTaking people
A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis
Where
Catania, Padova, Rome
Életkor
4 év to 17 év
People
110 worldwide
Run by
Takeda
See details and how to joinNCT07250802 · EU 2025-522567-15-00
3. fázisTaking people
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
Where
Ancona, Florence, Milan, Padova, Pisa, Rome, Rozzano
Életkor
18 év and over
People
1182 worldwide
Run by
Takeda
See details and how to joinNCT07286058 · EU 2025-522586-30-00
3. fázisTaking people
A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
Where
Florence, Milan, Rome
Életkor
5 év to 17 év
People
40 worldwide
Run by
AbbVie
See details and how to joinNCT06100744 · EU 2023-506026-36-00
No phaseTaking people
Clinical Study on the Medical Devices PROXERA PSOMED 20 and PROXERA PSOMED 40 for the Treatment of Plaque Psoriasis and Non-pustular Palmoplantar Psoriasis
Where
Chieti
Életkor
18 év to 65 év
People
35
Run by
ICIM International S.r.l.
See details and how to joinNCT07545902
No phaseTaking people
Clinical Study on the Medical Device PROXERA PSOMED 30 for the Treatment of Nail Psoriasis: Evaluation of Safety and Efficacy
Where
Chieti
Életkor
18 év to 65 év
People
21
Run by
ICIM International S.r.l.
See details and how to joinNCT07546032
3. fázisTaking people
A Phase 3 Multicenter, Randomized, Double-blind, Placebo-controlled and Deucravacitinib Active Comparator-controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis
Where
Cagliari, Ferrara, Milan, Naples, Novara
Életkor
18 év and over
People
320 worldwide
Run by
Janssen - Cilag International
See details and how to join2023-505121-14-00 · EU 2023-505121-14-00
No phaseTaking people
An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
Where
Ancona, Brescia, Campobasso, Catania, Chieti, Milan, Naples, Pisa, Rome, Rozzano, Siena, Udine
Életkor
18 év to 75 év
People
1200 worldwide
Run by
AbbVie
See details and how to joinNCT06764693
3. fázisTaking people
Study to Assess Efficacy, Safety and Tolerability of a Nail Patch in Patients With Nail Fragility, Mychosis, Psoriasis
Where
Milan
Életkor
18 év and over
People
72
Run by
Wooshin Labottach Co., Ltd.
See details and how to joinNCT07029516
No phaseNot yet taking people in Olaszország
LANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in Italian Clinical Practice
Where
Rozzano
Életkor
12 év and over
People
20 000
Run by
Fondazione ISIDE
See details and how to joinNCT07336641
No phaseTaking people
Dietary Approach to Mild-to-moderate Psoriasis
Where
Palermo
Életkor
18 év to 65 év
People
82
Run by
University of Palermo
See details and how to joinNCT05644782
No phaseTaking people
Evaluation of Stigma Toward Patients With Alopecia Areata, Atopic Dermatitis, Vitiligo, and Psoriasis
Where
Roma
Életkor
18 év and over
People
400
Run by
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06801821
4. fázisTaking people
Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study.
Where
Rome
Életkor
18 év to 80 év
People
26
Run by
Fondazione Policlinico Universitario Campus Bio-Medico
See details and how to joinNCT06974474
No phaseTaking people
Immune Infiltrate Analysis of Psoriasis Skin During Therapy With Anti-interleukin 23 (IL-23)
Where
Rome
Életkor
18 év and over
People
20
Run by
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
See details and how to joinNCT06792487
No phaseTaking people
International Rare And Severe Psoriasis Expert Network
Where
Rome
Életkor
6 hónap and over
People
180 worldwide
Run by
University Hospital, Basel, Switzerland
See details and how to joinNCT04359394